vTv Therapeutics
VTVT
36 hedge funds and large institutions have $29.1M invested in vTv Therapeutics in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 4 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
19% more capital invested
Capital invested by funds: $24.4M → $29.1M (+$4.7M)
3% more funds holding
Funds holding: 35 → 36 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.2M |
| 2 |
Renaissance Technologies
New York
|
+$295K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$184K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$112K |
| 5 |
Morgan Stanley
New York
|
+$79.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
-$1.56M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$491K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$423K |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$314K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$92.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TG
26
TLP Group
Evanston,
Illinois
| $84K | +$70.1K | +291 | New |
|
|
TA
27
Teachers Advisors
New York
| $42K | – | – | – |
|
|
NFA
28
Nationwide Fund Advisors
Columbus,
Ohio
| $35K | – | – | – |
|
|
AIG
29
American International Group
New York
| $31.7K | – | – | – |
|
30
New York State Common Retirement Fund
Albany,
New York
| $31K | – | – | – |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $9K | – | – | – |
|
32
BNP Paribas Financial Markets
Paris,
France
| $4.34K | +$1.2K | +5 | +50% |
|
33
Bank of America
Charlotte,
North Carolina
| $3K | +$963 | +4 | +67% |
|
34
BlackRock
New York
| $1K | – | – | – |
|
|
TCIM
35
TIAA CREF Investment Management
New York
| $126 | – | – | – |
|
|
DCM
36
DAFNA Capital Management
Los Angeles,
California
| – | -$423K | -1,825 | Closed |
|
|
KCM
37
Kennedy Capital Management
St Louis,
Missouri
| – | -$314K | -1,353 | Closed |
|
|
SO
38
STRS Ohio
Columbus,
Ohio
| – | -$12K | -50 | Closed |
|
|
BJ
39
BlackRock Japan
Tokyo,
Japan
| – | -$4K | -19 | Closed |
|
40
Barclays
London,
United Kingdom
| – | +$241 | +1 | New |
|
VTVT Hedge Fund Activity: Q3 2016 in Review
36 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2016, worth a combined $29.1M — up 19% from $24.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VTVT positions and 4 closed out — a net gain of 1 holder — while 11 added to existing stakes and 6 trimmed.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.2M. The largest seller was Piper Sandler & Co, cutting an estimated $1.56M.
- 36 institutional investors held vTv Therapeutics (VTVT) as of Q3 2016, up from 35 in Q2 2016.
- Funds reported $29.1M of vTv Therapeutics stock for Q3 2016, up 19% quarter-over-quarter.
- 5 funds opened new vTv Therapeutics positions in Q3 2016 and 4 closed out, a net change of +1 holder.
- The largest vTv Therapeutics buyer in Q3 2016 was Sphera Funds Management, an estimated $1.2M added.
- The largest vTv Therapeutics seller in Q3 2016 was Piper Sandler & Co, an estimated $1.56M sold.
Based on aggregated 13F filings for Q3 2016.